Red Knight
An obscure indica-leaning hybrid with limited documentation and almost no verifiable chemistry data outside vendor marketing.
Red Knight is one of those strain names that floats around seed catalogs and dispensary menus without a clear paper trail. There is no peer-reviewed chemistry on it, no breeder of record that we can verify, and what gets sold under the name varies between sellers. If a budtender tells you it's a specific phenotype with specific effects, treat that as marketing copy. Buy by the lab report on the jar in front of you, not by the name.
Overview
Red Knight is a cannabis strain name that appears on seed bank pages, dispensary menus, and crowdsourced strain databases, but lacks the kind of breeder documentation, lab analysis, or journalistic coverage that would let us describe it with confidence. Multiple unrelated cultivars have been sold under similar 'Knight' names, and Red Knight itself does not appear in any peer-reviewed chemotype survey that we can locate. No data
This article documents what is and isn't known, rather than repeating vendor copy as if it were fact. Readers looking for a specific, reproducible experience should rely on the certificate of analysis (COA) for the exact batch they are buying — see Reading a Cannabis COA — not on the name 'Red Knight.'
Chemistry
There is no published cannabinoid or terpene profile for Red Knight in peer-reviewed literature or government testing datasets we can verify. No data
Vendor listings sometimes report THC in the 15–22% range and negligible CBD, which is unremarkable and consistent with most modern THC-dominant flower on the legal market [1]. Without a batch-level COA, claims about the dominant terpene (myrcene, caryophyllene, limonene, etc.) for Red Knight are not verifiable.
A broader point: even when a strain does have a published chemotype, individual harvests vary substantially with genetics expression, light, nutrients, and curing. Studies of commercial cannabis have repeatedly found that samples sharing a strain name can differ more from each other than they do from differently-named strains [2][3]. Red Knight is unlikely to be an exception.
Reported effects
Effects descriptions for Red Knight on consumer sites are user-submitted, unblinded, and self-selected — i.e., anecdotal. Anecdote No clinical trial has tested Red Knight specifically, and we are not aware of any that ever will: clinical cannabis research generally uses standardized THC:CBD preparations, not branded strain names [4].
The broader 'indica vs. sativa predicts effects' framework that anchors most strain marketing is not supported by the available chemistry data. A 2022 analysis of nearly 90,000 commercial samples found that indica/sativa labels did not reliably map onto cannabinoid or terpene profiles [3]. If Red Knight is marketed as a 'relaxing indica,' that label is folklore, not pharmacology. Disputed
What is reasonable to expect from any THC-dominant flower at typical potencies is documented elsewhere — see THC Effects. Whether a particular Red Knight harvest produces a sedating versus stimulating experience depends on the specific chemotype of that batch, the dose, your tolerance, and set and setting.
Lineage
Lineage for Red Knight is disputed and undocumented. Disputed There is no breeder-of-record statement we can point to, and crowdsourced strain databases either omit parentage or list it as unknown. Some online listings speculate that the name is a rebrand or phenotype selection of more established red-pheno strains (e.g., crosses involving Pink Panties, Red Headed Stranger, or various 'Red' lines), but we have not found any primary source — breeder interview, seed company catalog with provenance, or court filing — that confirms this.
In the absence of verifiable lineage, 'Red Knight' should be treated as a name attached to whatever a given seller is moving, not as a stable genetic line. This is common with minor or regional strain names; see Strain Names and Genetic Drift for why this happens.
Cultivation basics
Because no verified breeder has published grow notes for Red Knight, cultivation guidance is speculative. No data Vendor pages reporting 8–9 week flowering, moderate stretch, and moderate yields are restating generic indica-hybrid expectations rather than measured data on this specific cultivar.
If you are growing seed or clone sold under the Red Knight name, treat it as an unknown phenotype: start with conservative feeding, watch the first run for stretch and node spacing, and take clones from the keeper. General indoor cannabis fundamentals — VPD, light intensity, defoliation timing — apply here as they do to any unfamiliar cultivar. See Growing Unknown Genetics.
Marketing vs. reality
What gets sold as Red Knight benefits from a few classic strain-marketing tactics worth flagging:
- Evocative name, no provenance. A memorable name does not imply a documented breeder or stable genetics.
- 'Indica' shorthand for 'relaxing.' This is folklore. Indica/sativa labels do not reliably predict effects from chemistry [3]. Strong evidence
- Vendor-reported THC percentages. Self-reported potency numbers in retail cannabis are frequently inflated relative to independent testing [5]. Strong evidence
- Borrowed terpene claims. Without a batch COA, any specific terpene claim for Red Knight is unsupported.
None of this means Red Knight is bad flower. It means the name itself carries very little information. Judge what's in the jar by the COA and your own response, not by the label.
Sources
- Peer-reviewed ElSohly, M. A., et al. (2021). A Comprehensive Review of Cannabis Potency in the USA in the Last Decade. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 6(6), 603–606.
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Peer-reviewed Watts, S., McElroy, M., Migicovsky, Z., Maassen, H., van Velzen, R., & Myles, S. (2021). Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 7, 1330–1334.
- Peer-reviewed National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
- Peer-reviewed Schwabe, A. L., Johnson, V., Harrelson, J., & McGlaughlin, M. E. (2023). Uncomfortably high: Testing reveals inflated THC potency on retail Cannabis labels. PLOS ONE, 18(4), e0282396.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.